Article: Curbing the common cold?(research indicates pleconaril reduces severity and duration of colds and possibly other viral infections)(Brief Article)

A new drug helps fight viruses responsible for the common cold. These pathogens, known as rhinoviruses, need to subtly alter the shape of their outer shell in order to infect cells. The drug, called pleconaril, blocks that shift.

People taking pleconaril did not suffer sore throats and stuffy noses as long as people getting a placebo did, says Frederick G. Hayden of the University of Virginia School of Medicine in Charlottesville. He found that 347 adults with moderate or severe colds suffered for 10.5 days when given pleconaril. The 168 people ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!